ライフサイエンスコーパス: plasma selenium

1 d function, despite significant increases in plasma selenium.

2 It has been observed previously that plasma selenium and glutathione levels are subnormal in

3 the context of established relations between plasma selenium and risk of cancer and mortality, and re

4 telet glutathione peroxidase activity and in plasma selenium and selenoprotein P concentrations were

5 ly demonstrated a strong interaction between plasma selenium and the manganese superoxide dismutase (

6 igh levels of blood cadmium or low levels of plasma selenium and the NLRP3 haplotype C-A-A-C multipli

7 protein is <20 mg/L (plasma zinc), <10 mg/L (plasma selenium and vitamins A and D), or <5 mg/L (vitam

8 Plasma selenium and whole-blood GPx activity were measur

9 tions were positively associated with infant plasma selenium at 2 or 6 and 24 wk postpartum (P < 0.00

10 erved only for men with a deficient level of plasma selenium, but healthy dietary sources should be r

11 The association between plasma selenium concentration and prostate cancer risk w

12 We measured plasma selenium concentration and the two plasma selenop

13 The mean baseline plasma selenium concentration for all subjects was 95.7

14 Plasma selenium concentration is decreased in patients w

15 Mean (SD) plasma selenium concentration was 88.5 ng/g (19.1) at ba

16 Mean plasma selenium concentration was 88.8 ng/g (SD, 19.2) a

17 Overall, plasma selenium concentration was not associated with pr

18 Plasma selenium concentration was not associated with pr

19 study was to investigate the association of plasma selenium concentration with subsequent prostate c

20 meta-analysis indicated that an increase in plasma selenium concentrations above 100 mug/L did not f

21 Plasma selenium concentrations decreased over the study

22 By 9 mo, mean (+/-SEM) plasma selenium concentrations had increased from 1.78 +

23 elenium and dietary intakes coupled with low plasma selenium concentrations in HIV infection could ha

24 nfant (55.6 +/- 16.3 to 61.0 +/- 15.4 mug/L) plasma selenium concentrations increased, whereas breast

25 -gene interaction was apparent when baseline plasma selenium concentrations were included in the regr

26 Plasma selenium concentrations were significantly correl

27 ted immune activation (plasma neopterin) and plasma selenium concentrations.

28 immune activation was associated with lower plasma selenium concentrations.

29 e further stratified by tertiles of baseline plasma selenium concentrations.

30 entation in individuals with relatively high plasma selenium concentrations.

31 Plasma selenium declined in proportion to the severity o

32 Plasma selenium-dependent glutathione peroxidase activit

33 microg/mL) was not seen in any subjects, and plasma selenium in 244 HIV-positive subjects (0.120 +/-

34 However, baseline plasma selenium in our study (x: 91 microg/L) was somewh

35 Thus, although plasma selenium is decreased in patients with cirrhosis,

36 diabetes in the highest tertile of baseline plasma selenium level (hazard ratio, 2.70 [CI, 1.30 to 5

37 adient was found across tertiles of baseline plasma selenium level, with a statistically significantl

38 Selenium deficiency (plasma selenium < 0.070 microg/mL) was not seen in any s

39 n the highest than in the lowest quartile of plasma selenium (P for linear trend = 0.04).

40 As part of the study, plasma selenium, thyroid-stimulating hormone, and total

41 Plasma selenium was increased more by 400 mug Se as sele

42 nd young adults, we examined the relation of plasma selenium, whole-blood glutathione, and whole-bloo

43 ignificant differences in the association of plasma selenium with risk when analyzed by stage or grad